PathologyWatch Welcomes Carlos Ricotti, MD, as a Key Addition to the Team

Dr. Ricotti brings seasoned expertise in complex dermatopathology cases to the firm.

SALT LAKE CITY—JANUARY 12, 2022—PathologyWatch, a full-service digital pathology lab, is pleased to welcome Carlos Ricotti, MD, to its clinical team.

Dr. Ricotti is a dermatologist and dermatopathologist whose expertise in complex cases—particularly basal cell carcinoma, melanoma, squamous cell carcinoma, autoimmune conditions and inflammatory skin conditions—keeps his skills in demand. His compassionate and professional methods of care align with PathologyWatch’s goals to support the most comprehensive and best-quality patient care while reducing healthcare costs.

“Dr. Ricotti’s approach to dermatopathology extends beyond the specimen slide and stays focused on the overall condition and health of the patient,” says Greg Osmond, chief medical officer and PathologyWatch cofounder. “His diverse experience in identifying and treating often aggressive malignant skin conditions is a tremendous benefit to the Florida communities we serve.”

Ricotti, who is US board certified and a diplomate in dermatology and dermatopathology, views himself as a clinician. Among his standout skills is the ability to delve into unique cases by analyzing information from different areas of a patient’s profile, in addition to the test slide, to uncover answers. “I really like complex dermatology,” says Ricotti. ”And I knew that dermpath would help me better understand complex skin diseases.”

He is often consulted to review cases where essential indicators may have been overlooked. He also shares his uniquely methodical process with residents with whom he works regularly. “I just try to stay informed because I think that’s the right way to do things,” he said.

“His keen eye for examining atypical cases by exploring the complete patient profile rather than just the slide is a major contributing factor that he brings to the PathologyWatch team,” says Michael Torno, CRO and cofounder at PathologyWatch. “That approach to dermatopathology is the future of dermatological care and will enhance the patient experience for our clients.”

Dr. Ricotti completed a fellowship in dermatopathology at the University of Texas Southwestern and his residency in dermatology at the University of Miami. He is frequently consulted for his expertise and has contributed to several publications, including peer-reviewed scientific journals and book chapters for dermatology texts.

For more information, please email [email protected]hologywatch.com or visit us at pathologywatch.com.

About PathologyWatch
PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through these services, dermatology clinics, hospitals and laboratories can improve operational efficiency by speeding up workflow and enhancing patient outcomes by utilizing the PathologyWatch expert professional team and in-house lab services. With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision-making to deliver unprecedented patient care.

PathologyWatch Raises $25M to Advance AI-Driven Skincare Research and Diagnostics

The Series B funding round will help PathologyWatch digitize biopsies, increase access to top skincare physicians and further AI research.

SALT LAKE CITY, November 16, 2021—PathologyWatch, the leading digital lab and pathology platform for dermatologists, announced today that it has raised $25M in Series B financing with participation from Ceros Capital Markets, Rock Creek Capital, SpringTide, Spark Growth Ventures, Blueprint Health, Blackbrook Management Group and existing investors.

With the new funding, PathologyWatch will broaden its outreach to dermatologists and conduct further research into skincare diagnostics and AI – allowing patients to receive faster diagnoses and more equitable access to dermatopathology services while enabling labs to work more efficiently and cost-effectively. Additionally, the funding will support operations as the business expands across the country, adding new labs in Texas, Florida and Arizona.

“We are honored that of all the digital dermpath labs available, dermatologists are increasingly choosing to partner with us,” said Dan Lambert, PathologyWatch CEO and cofounder. “As digital dermatopathology continues to grow, it has the potential to reduce the costs of pathology by billions while creating better patient care for everyone across the country. We’re thrilled to be winning so much volume so quickly.”

PathologyWatch provides fully interfaced EMR reporting and 24/7 access to digital slides for dermatology clinics. For their clients, this means more-efficient workflows and direct access to leading dermatopathologists across the country, with broad insurance coverage. PathologyWatch has successfully integrated laboratory information systems, scanners, digital viewer technology and EMRs into an end-to-end solution for dermatologists.

“PathologyWatch has been disruptive to the market and is digitally transforming the industry in unprecedented ways,” said Mark Goldwasser, CEO of Ceros. “With the need for remote health services during COVID, the distributed network of top-tier dermatopathologists alongside a digital viewer that can be accessed anytime and anywhere could not have come at a more fortuitous time.”

“For a dermatology practice to send nearly all skin biopsy volume for cancer diagnosis to PathologyWatch is a no-brainer,” said Austin Walters, founder and managing partner at SpringTide. “The company has worked hard to create a service that outperforms every other from both cost and quality perspectives.”

“Dan is a driven entrepreneur with social good in mind,” said Ryan Brooks, principal at Blackbrook Management Group. “We are part of a cause, not just an investment capital endeavor. In the past, I have been a patient waiting for pathology to come back. When you are waiting for results that could change your life dramatically, you want doctors and tech you can depend on. PathologyWatch will enhance the human experience and enable dermatopathologists to do a better job.”

“I am proud to support PathologyWatch’s mission to provide premier, accessible and affordable digital pathology services to the world,” said Rick Stratford, managing director of Rock Creek Capital. “The ability to provide top-tier pathology services to all communities regardless of location brings hope to patients in underserved areas and can save countless lives. PathologyWatch and other digital platforms like it are democratizing healthcare services and bringing hope and change to our healthcare systems.”

For more information about PathologyWatch, visit pathologywatch.com or contact [email protected]

About PathologyWatch
PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through these services, dermatology clinics, hospitals and laboratories can improve operational efficiency by speeding up workflow and enhancing patient outcomes by utilizing the PathologyWatch expert professional team and in-house lab services. With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision-making to deliver unprecedented patient care.

PW Recognized as One of Utah’s Fastest Emerging Companies 2021

The PathologyWatch team is thrilled and honored to be on the Utah Business Magazine’s Emerging Growth 2021 Fast 50 List of the state’s fastest-growing companies!

Utah Business and Bind Benefits hosted this year’s Fast 50 Awards Celebration on August 26th, 2021, at the Grand America Hotel in downtown Salt Lake City.

What Is a Fast 50 Emerging Company?

Fast 50 Award Lunch 2021

Each year, Utah Business (UB) presents a special category that showcases emerging companies that display exponential growth. PathologyWatch was one of those companies. 

UB celebrates these companies for their rapid revenue growth and business strategies, but the entrepreneurial spirit also inspires them.

PathologyWatch was honored as the groundbreaking leader of digital dermatopathology services, brilliantly combining state-of-the-art technology and clinical decision-making to deliver exceptional patient care.

Company rankings will be published in the September issue of Utah Business magazine.

To read the complete list of companies, click here

 

Greg Osmond Fast 50 2021

PathologyWatch Boasts Key Addition to Its Roster of Dermatopathologists with Allison Readinger, MD

A leader in dermatology and dermatopathology, Allison Readinger, MD, joins PathologyWatch’s clinical team to assist in the growing landscape of digital healthcare.

Salt Lake City—March 7, 2021—PathologyWatch, a full-service digital pathology service, is pleased to welcome Allison Readinger, MD, to its clinical team. A highly qualified and respected dermatologist and dermatopathologist, Readinger brings a wealth of industry knowledge and innovation, coinciding with PathologyWatch’s mission to preserve and extend life for patients while reducing healthcare costs.

“We are pleased to have Dr. Readinger join us as a member of our clinical team. Her industry expertise and seasoned leadership skills make her a genuine asset,” said Dan Lambert, cofounder and chief executive officer of PathologyWatch. “Together, we are eager to expand our reach across the Texas market, positively impacting the lives of our healthcare providers and their patients.”

An alumnus of the University of Texas Medical Branch at Galveston, Readinger is a board-certified dermatologist and dermatopathologist with over 15 years of experience. In October 2010, she opened Trinity Vista Dermatology to offer more dermatology services to the rapidly growing population of Fort Worth, Texas.

Readinger recently served as President of the Texas Dermatological Society and continues to advocate for patients, for physician and resident education, and for her specialty.

At her core, Readinger enjoys bonding with her patients, providing excellent care, and being at the forefront of advances in medical technology. With an understanding of the importance of attention to detail and personalized care in modern medicine, she makes an excellent addition to the PathologyWatch family.

“I am thrilled to be a part of the continued growth of digital dermatopathology,” said Readinger. “The landscape of digital dermatopathology is growing at a rapid pace, and I am eager to assist in the continued growth and progress of our field.”  She adds, “I hope to utilize digital dermatopathology to expand further my ability to offer great clinicopathologic correlation to my clients.”

For more information, please email [email protected] or visit us at pathologywatch.com.

About PathologyWatch
PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through these services, dermatology clinics, hospitals and laboratories can improve operational efficiency by speeding up workflow and enhancing patient outcomes by utilizing the PathologyWatch expert professional team and partner laboratory services. This can facilitate best-in-class reads and, in some cases, enable additional revenue to the practice by in-housing pathology. With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision-making to deliver unprecedented patient care.

PathologyWatch Announces Key Hire to Bolster Digital Dermatopathology Practice

Darren Whittemore, DO, joins the PathologyWatch team to support the delivery of optimal patient outcomes.

SALT LAKE CITY—DECEMBER 8, 2020—PathologyWatch, a full-service digital dermatopathology solution, is pleased to welcome Dr. Darren Whittemore, DO, to the growing PathologyWatch family. A qualified and respected dermatopathologist, Whittemore will be instrumental in establishing processes to ensure dermatology clinics receive the highest level of digital pathology services.  

Board certified in anatomic and clinical pathology and dermatopathology, Whittemore was fellowship-trained at the University of Texas Health Science Center after completing his residency at the combined US Air Force Wilford Hall Medical Center/Brooke Army Medical Center program.

“Dermatopathologists play a critical role in a patient’s recommended treatment,” said Dan Lambert, CEO and cofounder of PathologyWatch. “With expertise and attention to detail, Dr. Whittemore utilizes innovative advances in digital pathology to deliver the highest quality of care and efficiency to patients.”

Whittemore brings extensive subspecialty experience and proven abilities in diagnosing alopecia cases to PathologyWatch. Also, he embraces new technologies and the growing role they play in understanding the pathogenesis of diseases. 

“With advantages that include enhanced clinicopathologic correlation, improved turnaround time and paperless, electronic workflows, digital dermatopathology represents the future of the dermatology industry,” Whittemore said. “Joining PathologyWatch places me in the heart of this burgeoning technology with individuals who are committed to helping dermatology clinics deliver industry-leading care to their patients.”

For more information on PathologyWatch, please visit pathologywatch.com.

About PathologyWatch
PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through these services, dermatology clinics, hospitals and laboratories can improve operational efficiency by speeding up workflow and enhancing patient outcomes by utilizing the PathologyWatch expert professional team and partner laboratory services. This can facilitate best-in-class reads and, in some cases, enable additional revenue to the practice by in-housing pathology. With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision-making to deliver unprecedented patient care.

View the original release.

PathologyWatch Announces Locum Tenens Dermatopathology Services

Full-service lab PathologyWatch now provides remote, academic-level dermatopathology services to laboratories in need of temporary or long-term support.

Digital dermatopathology service provider PathologyWatch is now offering top-tier dermatopathology services to laboratories in need of temporary or long-term locum tenens support. Utilizing the advantages of digital pathology, PathologyWatch provides instant remote access to a workforce of academic-level dermatopathologists.

Commonly, a laboratory in need of locum tenens assistance is responsible for providing travel arrangements, lodging and per diem to attract qualified talent. Using an integrated digital pathology system, PathologyWatch eliminates costly overhead by offering a network of expert dermatopathologists available 24/7 for consultation. As a result, laboratories find a seamless transition to help them to continue running at full capacity.

“Providing locum tenens support to companies experiencing overflow due to staffing or seasonal variables is the next logical step for PathologyWatch,” says CEO and co-founder Dan Lambert. “Our locums tenens support is ideal for pathology labs and dermatology clinics that have a limited number of in-house dermatopathologists. The on-demand services require no minimum or advanced notice. When dermatopathologists have an influx of samples, have a life event, or even want to take a vacation, they can simply turn on the services for as long as they need them.”

In addition to a significant reduction in travel costs, PathologyWatch provides labs with 24/7 digital access to all pathology slides without purchasing a scanner. This also includes improved access to subspecialists and second opinions. Meanwhile, extensive insurance coverage means PathologyWatch can accommodate the majority of laboratory customers nationwide.

“Using PathologyWatch for locums coverage has given me access to high-quality dermatopathologists when I needed the coverage with ease and flexibility,” said Emily Green, dermatopathology lab director at Golden State Dermatology. “I highly recommend their services.”

For more information on PathologyWatch, please visit PathologyWatch.com. PathologyWatch follows all state and federal regulations. As such, the specific coverage arrangement may vary from state to state.

About PathologyWatch

PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through these services, dermatology clinics, hospitals and laboratories can improve operational efficiency by speeding up workflow and enhance patient outcomes by utilizing the PathologyWatch expert professional team and partner laboratory services. This can facilitate best-in-class reads and, in some cases, enable additional revenue to the practice by in-housing pathology. With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision making to deliver unprecedented patient care.